Invention Grant
- Patent Title: Combination therapy
-
Application No.: US16639088Application Date: 2018-08-14
-
Publication No.: US11351176B2Publication Date: 2022-06-07
- Inventor: Daniel P. Gold
- Applicant: MEI Pharma, Inc.
- Applicant Address: US CA San Diego
- Assignee: MEI Pharma, Inc.
- Current Assignee: MEI Pharma, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/046742 WO 20180814
- International Announcement: WO2019/036489 WO 20090211
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61P35/00 ; C07K16/28 ; A61K9/00
Abstract:
Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a CD20 inhibitor to a patient.
Public/Granted literature
- US20200222415A1 COMBINATION THERAPY Public/Granted day:2020-07-16
Information query
IPC分类:
